天智航(688277.SH):擬與關聯方合作開展科研項目
格隆匯12月6日丨天智航(688277.SH)公佈,為了推進“機器人工程技術與創新應用研究中心”科研項目建設,同時聚集公司運營發展所需要的外部資源,形成醫療器械協同創新生態體系,公司擬與邦泰天璣智能醫療創新中心開展合作,由邦泰天璣智能醫療創新中心負責為“機器人工程技術與創新應用研究中心”培育孵化落地合肥本地的醫療器械企業2家,公司向其撥付專項經費300萬元。該中心繫經安徽省、合肥市批准的科研項目“合肥綜合性國家科學中心醫工融合醫療裝備創新研究平台項目”下建設的四個中心之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.